• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY ORBERA INTRAGASTRIC BALLOON SYSTEM; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY ORBERA INTRAGASTRIC BALLOON SYSTEM; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY Back to Search Results
Device Problem Difficult to Remove (1528)
Patient Problems Airway Obstruction (1699); Respiratory Insufficiency (4462)
Event Date 02/01/2024
Event Type  Injury  
Event Description
It was reported to boston scientific corporation that an orbera intragastric balloon system was used on an unknown procedure performed on an unknown date.The account reported difficulty removing the device without the official removal kit (prince medical removal kit) regarding the previous removal treatment for one patient last month, although he could finally remove it, he has failed several times to remove orbera during the treatment even though he tried based on the recommendation on how to use general needle and forceps to remove it.He experienced during surgery that the balloon got stuck in the esophagus and the patient almost suffocated.The physician does not want to do the same removal treatment with general instrument as he believes it compromises patient safety.And he strongly requests to ship official removal kits to japan.Or if a satisfactory solution is not presented to him, he will be exploring a legal option.Apollo had continuously accepted the order of removal kits form japanese doctors at the same timing as orbera before and shipped at the same time of orbera as an official or recommended removal kit.A final decision for the delivery of bsc's official removal kits is required at this time since this physician has another patient scheduled for orbera removal.He must plan the removal treatment for another patient within this month according to the removal period of orbera.
 
Manufacturer Narrative
Block b3: approximated based on the date the manufacturer became aware of the event.Block h6: imdrf code e0702 is being used to capture the reportable event of airway obstruction.Imdrf code e0743 is being used to to capture the reportable event of respiratory insufficiency.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA INTRAGASTRIC BALLOON SYSTEM
Type of Device
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY
Manufacturer (Section D)
APOLLO ENDOSURGERY
1120 s. capital of texas hwy
bldg 1 suite 300
austin TX 78746
Manufacturer (Section G)
APOLLO ENDOSURGERY COSTA RICA S.R.L
alajuela, 02
CS  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key18791177
MDR Text Key336361585
Report Number3005099803-2024-00785
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 02/27/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/02/2024
Initial Date FDA Received02/27/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-